Welcome to Targeting Phage Therapy
Keynote Speech 2024: Prof. Robert T. Schooley
It is a great pleasure to welcome Prof. Robert Schooley, from University of California, San Diego (USA) as a key note speaker during Targeting Phage Therapy 2024, this June in Malta.
Speakers Lineup 2024
Phage Therapeutics 2024: The Critical Role of Translational Research in Clinical Trials
Robert T. SchooleyUniversity of California, San Diego, USA
Adaptive Phage Therapy in The Intensive Care Unit: From Science to Patients
Ekaterina ChernevskayaFederal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Russia
Magistral Phage Preparations: Is This the Model for Everyone?
Jean-Paul PirnayQueen Astrid Military Hospital, Belgium
Regulatory restrictions vs. Human Rights, the Hippocratic oath and the Freedom of therapy– The legal aspect of phage therapy
Barbara BrennerKanzlei BRENNER, Germany
Phage Therapy: A Glimpse into Clinical Studies Involving Over 150 Cases
Nannan WuShanghai Public Health Clinical Center, Fudan University, China
Mycobacteriophages and Their Therapeutic Potential
Graham F. HatfullUniversity of Pittsburgh, USA
Genetic Engineering of Phages to Target Intracellular Bloodstream E.coli Infections
Antonia P. SagonaUniversity of Warwick, United Kingdom
Developing Phage Therapy Through an Evolutionary-Medicine Lens
Paul TurnerYale University, USA
Quality control of phage Active Pharmaceutical Ingredients (APIs) in Belgium
Pieter-Jan CeyssensSciensano, Belgium
The Phageome in Normal and Inflamed Human Skin
Wolfgang WeningerMedical University of Vienna, Austria
Phage Satellites, a Diversity of Extradimensional Symbionts and Pathways to Phage Therapy
Rodrigo Ibarra ChávezUniversity of Copenhagen, Denmark
Towards efficient phage therapies: investigation of phage / bacteria equilibrium with metagenome of dark matter in natural samples
Domenico FrezzaUniversity of Roma Tor Vergata, Italy
Cell-Free Production of Personalized Therapeutic Phages Targeting Multidrug-Resistant Bacteria
Kilian VogeleInvitris, Germany
The untapped potential of phage model systems as therapeutic agents
Frederic BertelsMax Planck Institute for Evolutionary Biology, Germany
Evolution and megataxonomy of viruses: the place of phages in the virosphere
Eugene V KooninNational Institutes of Health, USA
Addressing Phage Resistance to Enhance the Robustness of Phage Therapy for Pseudomonas aeruginosa Infections in People with Cystic Fibrosis
Federica BrianiUniversity of Milan, Italy
Phage therapy: Targeting intestinal bacterial microbiota for the treatment of Liver disease
Jumpei FujikiUniversity of California San Diego, USA
Save the Dates
Who is Attending Targeting Phage Therapy 2024?
Precision Phage (Sponsor)
PHAXIAM Therapeutics
Rime Bioinformatics
Phage Consulting
Intralytix, Inc.
Invitris
Sciensano
Vivantes
Laboratorios Syva S.A.U.
Agricultural University of Athens
Centro De Calidad Avícola Y Alimentación Animal De La Comunidad Valenciana
CHU Helora Mons
Ciberes-IDIBAPS
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology
Fudan University
Goethe University Frankfurt
Hannover Medical School
Kanzlei BRENNER
KU Leuven
Leibnitz Institute of Fresh Water and Inland Fisheries
Masaryk University
Max Planck Institute for Evolutionary Biology
Medical University of Vienna
National Institutes of Health
NBT NHS Trust
Queen Astrid Military Hospital
Shanghai Public Health Clinical Center
Università degli Studi di Milano, Dip di Bioscienze
Universitat de València
Université Laval
University Hospital of Liège
University of California San Diego
University of Copenhagen
University of Helsinki
University of Liverpool
University of Milan
University of Pittsburgh
University of Roma Tor Vergata
University of Warsaw
University of Warwick
Victor Babes University of Medicine Timișoara
Yale University
Yıldız Technical University
17/04/2024